In addition, consistent with the finding that estrogen-mediated interleukin 6 suppresses the development of HCC19, the incidence of HCC in the control female mice was found to be only 16% in the present study (Fig. 4a, b). The gene discussed is IL6; the disease is hepatocellular carcinoma.